In 2000, Bloomage Biotech (formerly Bloomage Freda Biopharm Co., Ltd.) took its first steps as a producer of hyaluronic acid using microbial fermentation. After more than 20 years, Bloomage Biotech has emerged as a leading global biotechnology and biomaterial company specializing in hyaluronic acid industrialization. Bloomage Biotech is dedicated to improving people’s quality of life by creating healthier experiences.
Technology
By applying the excellent results of its foundational research, Bloomage Biotech has become a leader in core industry disciplines such as microbial fermentation, enzymatic degradation, and cross-linking. The company has twice revolutionized hyaluronic acid production using microbial fermentation and oligomeric hyaluronic acid production by enzyme digestion.
Products
Bloomage Biotech is on a ceaseless pursuit of "creating technology for a vibrant life." The company primarily focuses on functional sugars, proteins, polypeptides, amino acids, nucleotides, natura active compounds, and other biologically active substances based on hyaluronic acid. Our hyaluronic acid products encompass more than 200 specifications for pharmaceutical, cosmetic, and food-grade applications, which have been widely used in the fields of medicine, medical devices, cosmetics, and nutrition.
Quality
Bloomage Biotech's production of pharmaceutical-grade raw materials complies with the requirements of cGMP in the U.S., GMP in China, and ICHQ7. It has passed on-site audits by the FDA in the U.S., MFDS in Korea, and GMP in China. Bloomage Biotech's food-grade raw material production has been certified under ISO9001 and FSSC22000 food safety systems. Furthermore, the company's cosmetics-grade raw material production has obtained ISO9001 and EFfCI certifications.
Service
Bloomage Biotech is proud to be a trusted strategic partner of world-renowned brands, providing customers with comprehensive products, technical services, and application solutions to meet their unique product needs.
Currently, Bloomage Biotech has earned the trust of over 2,000 renowned global brands in more than 70 countries and regions, fostering close business relationships through delivering exceptional products. Building upon its success, the company has expanded its presence globally, establishing subsidiaries in the U.S., France, Japan, and South Korea. Bloomage Biotech remains committed to innovating and promises to offer even more robust, comprehensive products and solutions to its customers.
more >
Year of Establishment:
2000
Total Assets(USD):
More than 99,999,999
Total Number of Staff:
more than 1000
Main Competitive Advantages:
Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
Manufacturer
R&D capacity:
Own Brand
Annual Turnover(USD):
500,000 to 99,999,999
Main Sales Markets:
North America,Central/South America,Western Europe,Asia,Middle East
Other Competitive Advantages:
Patents and Copyrights: